Morbidity and mortality following Acoustic neuroma excision in the United States: Analysis of racial disparities during a decade in the radiosurgery era

Neuro-Oncology

Volumn 13, Issue 11, 2011, Pages 1252-1259

  McClelland III, Shearwood ^a,c   Guo, Hongfei ^b   Okuyemi, Kolawole S ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acoustic neuroma; Health disparities; Morbidity; Mortality; Neurosurgery

Indexed keywords

ACOUSTIC NEURINOMA; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER SURGERY; CAUCASIAN; COMPARATIVE STUDY; DEMOGRAPHY; FEMALE; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; INCOME; MALE; MORBIDITY; RACE; RACE DIFFERENCE; RADIOSURGERY; SURGICAL MORTALITY; TREATMENT OUTCOME; UNITED STATES; WORKLOAD;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEALTHCARE DISPARITIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; NEUROMA, ACOUSTIC; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80755189302     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor118     Document Type: Article

References (24)

1. Acoustic Neuroma. NIH Consensus Statement. 1991;9(4):1-24.
2. Wayman JW, Dutcher PO, Manzione JV, Nelson CN, Kido DK. Gadolinium-DPTA-enhanced magnetic resonance imaging in cerebellopontine angle tumors. Laryngoscope. 1989;99:1167-1170. (Pubitemid 19274811)
3. Bederson JB, Von Ammon K, Wichmann WW, Yasargil MG. Conservative treatment of patients with acoustic tumors. Neurosurgery. 1991;28:646-651.
4. Laasonen EM, Troupp H. Volume growth rate of acoustic neurinomas. Neuroradiology. 1986;28:203-207. (Pubitemid 16075026)
5. Myrseth E, Pedersen PH, Møller P, Lund-Johansen M. Treatment of vestibular schwannomas. Why, when and how? Acta Neurochir (Wien). 2007;149:647-660. (Pubitemid 47030305)
6. Gormley WB, Sekhar LN, Wright DC, Kamerer D, Schessel D. Acoustic neuromas: results of current surgical management. Neurosurgery. 1997;41(1):50-58.
7. Lanman TH, Brackmann DE, Hitselberger WE, Subin B. Report of 190 consecutive cases of large acoustic tumors (vestibular schwannoma) removed via the translabyrinthine approach. J Neurosurg. 1999;90(4):617-623. (Pubitemid 29152848)
8. Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol. 1988;97:55-66. (Pubitemid 18067482)
9. Haines SJ, Levine SC. Intracanalicular acoustic neuroma: Early surgery for preservation of hearing. J Neurosurg. 1993;79:515-520. (Pubitemid 23289807)
10. Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery. 1995;36:215-229.
11. Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med. 1998;339:1426-1433. (Pubitemid 28516065)
12. Shin M, Ueki K, Kurita H, Kirino T. Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet. 2002;360:309-310. (Pubitemid 34874725)
13. Myrseth E, Moller P, Pedersen PH, Vassbotn FS, Wentzel-Larsen T, Lund-Johansen M. Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery. 2005;56:927-935.
14. Andrews DW, Silverman CL, Glass J, et al. Preservation of cranial nerve function after treatment of acoustic neurinomas with fractionated stereotactic radiotherapy. Preliminary observations in 26 patients. Stereotact Funct Neurosurg. 1995;64:165-182. (Pubitemid 26201788)
15. Fuss M, Debus J, Lohr F, et al. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys. 2000;48:1381-1387.
16. Andrews DW, Suarez O, Goldman HW, et al. Stereotactic radiosurgery and fractionated radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys. 2001;50:1265-1278. (Pubitemid 32727805)
17. Curry WT, Jr, Carter BS, Barker FG, 2nd. Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004. Neurosurgery. 2010;66(3):427-438.
18. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract. 2002;5(3):143-51.
19. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27. (Pubitemid 128456396)
20. Barker FG, 2nd., Carter BS, Ojemann RG, Jyung RW, Poe DS, McKenna MJ. Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope. 2003;113(8):1332-1343. (Pubitemid 36944675)
21. Walsh RM, Bath AP, Bance ML, Keller A, Tator CH, Rutka JA. The role of conservative management of vestibular schwannomas. Clin Otolaryngol Allied Sci. 2000;25(1):28-39. (Pubitemid 30137852)
22. Raut VV, Walsh RM, Bath AP, et al. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study. Clin Otolaryngol Allied Sci. 2004;29(5):505-514. (Pubitemid 39287083)
23. Hajioff D, Raut VV, Walsh RM, et al. Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol. 2008;33(3):255-259. (Pubitemid 351799012)
24. Institute of Medicine. Access to Health Care in America: A Model for Monitoring Access. Washington, DC: National Academy Press; 1993.